Why the study?
Does implantable cardioverter-defibrillator implantation prevent sudden cardiac death in patients with congenital heart disease and inherited arrhythmia syndromes?
Does implantable cardioverter-defibrillator implantation prevent sudden cardiac death in patients with congenital heart disease and inherited arrhythmia syndromes?
This review highlights the complex risk stratification and guideline-based indications for ICD implantation to prevent sudden cardiac death in patients with congenital heart disease and inherited arrhythmia syndromes.
Answers are grounded in this paper and cite their sources.
May inform guideline-based ICD decisions in congenital heart disease and inherited syndromes; leaves open prospective validation of risk stratification.
heart disease (CHD) is increasing because medical and surgical care received during childhood has improved, resulting in an additional cohort at risk for malignant arrhythmias. However, ICD use in this generally younger patient population is complicated, with high rates of device-related complications occurring over many decades of use, including inappropriate shocks, device-related infections, and lead displacement or failure. 11 Furthermore, appropriate selection criteria for ICD implantation in these patients are poorly defined due to a paucity of randomized controlled trials in such patients. Current professional guidelines therefore rely on data from non-randomized studies and on expert opinion. his review describes available evidence-based risk stratification for SCD and current guideline-driven management strategies for the use of ICDs in patients with CHD and inherited arrhythmia syndromes.
No takes yet. Share an insight, caveat, or question.
Goldstein et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: